Recent PsA/AS FDA Approval of SIMPONI ARIA [transcript][audio]
Key Takeaways
- Key Insight: Segment Overview: Returning guest, Dr.
- Clinical Perspective: Arthur Kavanaugh discusses the recent (Oct 2017) FDA approval of SIMPONI ARIA ® (golimumab) as the first and only fully-human anti-tumor necrosis factor (TNF)-alpha therapy delivered via a 30-minu…
- Why It Matters: This discussion provides healthcare professionals with actionable insights relevant to clinical practice and patient care.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
Segment Overview: Returning guest, Dr. Arthur Kavanaugh discusses the recent (Oct 2017) FDA approval of SIMPONI ARIA ® (golimumab) as the first and only fully-human anti-tumor necrosis factor (TNF)-alpha therapy delivered via a 30-minute infusion for the treatment of adults living with active psoriatic arthritis (PsA).
Guest: Dr. Arthur Kavanaugh, MD
Presenter: Neal Howard
Guest Bio: Dr. Kavanaugh is a Professor of Medicine at University of California San Diego and a lead investigator for Janssen Biotech. He earned his AB (biology) at the Massachusetts Institute of Technology in Cambridge, MA. He earned his MD (Medicine) at St. Louis University Medical School in St. Louis, MO. His research interests include innovative strategies for the treatment of patients with rheumatoid arthritis and other rheumatic diseases. Prognostic and predictive factors for outcomes in rheumatic diseases. Research program on innovative approaches to various immunologic diseases, particularly novel biologic therapies. His clinical focus are rheumatoid arthritis, psoriatic arthritis, lupus, vasculitis, and scleroderma.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
